Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been considered promising therapeutic targets for cancer therapy. These cells have self-renewal capacity and differentiation potential and contribute to multiple tumor malignancies, such as recurrence, metastasis, heterogeneity, multidrug resistance, and radiation resistance. The biological activities of CSCs are regulated by several pluripotent transcription factors, such as OCT4, Sox2, Nanog, KLF4, and MYC. In addition, many intracellular signaling pathways, such as Wnt, NF-κB (nuclear factor-κB), Notch, Hedgehog, JAK-STAT (Janus kinase/signal transducers and activators of transcription), PI3K/AKT/mTOR (phosphoinositide 3-kinase/AKT/mammalian target of rapamycin), TGF (transforming growth factor)/SMAD, and PPAR (peroxisome proliferator-activated receptor), as well as extracellular factors, such as vascular niches, hypoxia, tumor-associated macrophages, cancer-associated fibroblasts, cancer-associated mesenchymal stem cells, extracellular matrix, and exosomes, have been shown to be very important regulators of CSCs. Molecules, vaccines, antibodies, and CAR-T (chimeric antigen receptor T cell) cells have been developed to specifically target CSCs, and some of these factors are already undergoing clinical trials. This review summarizes the characterization and identification of CSCs, depicts major factors and pathways that regulate CSC development, and discusses potential targeted therapy for CSCs.
Keywords: Cancer stem cells.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare no competing interests.
Resistance to Cell Death and Its Modulation in Cancer Stem Cells.Crit Rev Oncog. 2016;21(3-4):203-219. doi: 10.1615/CritRevOncog.2016016976. Crit Rev Oncog. 2016. PMID: 27915972 Free PMC article. Review.
Cancer stem cells (CSCs) in cancer progression and therapy.J Cell Physiol. 2019 Jun;234(6):8381-8395. doi: 10.1002/jcp.27740. Epub 2018 Nov 11. J Cell Physiol. 2019. PMID: 30417375 Review.
Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.Ther Adv Vaccines Immunother. 2019 Jan 25;7:2515135518821623. doi: 10.1177/2515135518821623. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 30719508 Free PMC article. Review.
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.Biochim Biophys Acta. 2012 Dec;1826(2):272-96. doi: 10.1016/j.bbcan.2012.04.008. Epub 2012 May 10. Biochim Biophys Acta. 2012. PMID: 22579961 Free PMC article. Review.
Targeting cancer stem cells in drug discovery: Current state and future perspectives.World J Stem Cells. 2019 Jul 26;11(7):398-420. doi: 10.4252/wjsc.v11.i7.398. World J Stem Cells. 2019. PMID: 31396368 Free PMC article. Review.